down arrow

ABL Diagnostics SA

  • Market Cap: N/A
  • Industry: Finance
  • ISIN: FR001400AHX6
EUR
3.10
-0.28 (-8.28%)

Dec 12

PAR

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About ABL Diagnostics SA stock-summary
stock-summary
ABL Diagnostics SA
Finance
Etablissements Fauvet-Girel SA is a France-based holding company. The Company is owned by SPACLO.
Company Coordinates stock-summary
Company Details
40 boulevard Henri Sellie , SURESNES None : 92150
stock-summary
Tel: 33 1 45061574
stock-summary
http://www.fauvet-girel.fr/
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Gilles Dambrine
Chairman of the Board, Chief Executive Officer
Mr. Bruno Dambrine
Director
Mr. Stephane Prefol
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2012)
Net Profit:
stock-summary
Industry

Finance

stock-summary
Market cap

EUR 49 Million ()

stock-summary
P/E

72.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.03%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

4.50%

stock-summary
Price to Book

7.78

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."